Serina Therapeutics SER
NYSE SER
$2.43 -0.14 (-5.36%)
As of: Sep 10, 2026 · 3:59 PM EDT

Serina Therapeutics (SER) Prepaid Assets (2017 - 2026)

Serina Therapeutics' (SER) quarterly Prepaid Assets came in at $2.0 million in Q2 2026, up 2.87% year-over-year from $2.0 million in Q2 2025, and down 33.66% quarter-over-quarter from $3.0 million in Q4 2025.

Analysis

Serina Therapeutics (SER) Prepaid Assets (2017 - 2026) Analysis & Trends

Serina Therapeutics has disclosed Prepaid Assets across 10 years of filings, most recently posting $2.0 million for Q2 2026.

  • In Q2 2026, Prepaid Assets rose 2.87% year-over-year to $2.0 million; the TTM figure through Jun 2026 stood at $2.0 million (up 2.87% YoY), while the FY2025 annual figure was $3.0 million, up 50.9% from the prior year.
  • Prepaid Assets came in at $2.0 million for Q2 2026 at Serina Therapeutics, down from $3.0 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $3.0 million in Q4 2025 to a low of $166000.0 in Q1 2024.
  • Average Prepaid Assets over 5 years is $1.7 million, with a median of $1.6 million recorded in 2022.
  • Year-over-year, Prepaid Assets plunged 88.64% in 2024 and soared 795.78% in 2025.
  • Over 5 years, Prepaid Assets stood at $1.8 million in 2022, then sank by 62.69% to $673000.0 in 2023, then jumped by 197.77% to $2.0 million in 2024, then soared by 50.9% to $3.0 million in 2025, then slumped by 33.66% to $2.0 million in 2026.
  • Per Business Quant data, the three most recent Prepaid Assets figures were $2.0 million in Q2 2026, $3.0 million in Q4 2025, and $2.9 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Serina Therapeutics 40.47 Mn 17.45 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.01 Mn
Dec 31, 2025 3.02 Mn
Sep 30, 2025 2.88 Mn
Jun 30, 2025 1.95 Mn
Mar 31, 2025 1.49 Mn
Dec 31, 2024 2.00 Mn
Sep 30, 2024 2.22 Mn
Jun 30, 2024 2.80 Mn
Mar 31, 2024 166,000.00
Sep 30, 2023 673,000.00
Jun 30, 2023 1.08 Mn
Mar 31, 2023 1.46 Mn
Dec 31, 2022 1.80 Mn
Sep 30, 2022 720,000.00
Jun 30, 2022 1.01 Mn
Mar 31, 2022 1.38 Mn
Dec 31, 2021 1.63 Mn
Sep 30, 2021 720,000.00
Jun 30, 2021 930,000.00
Mar 31, 2021 1.29 Mn